One-carbon metabolism and breast cancer: an epidemiological perspective

Journal of Genetics and Genomics

Volumn 36, Issue 4, 2009, Pages 203-214

  Xu, Xinran ^a   Chen, Jia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

breast cancer; DNA methylation; epidemiology; folate; genetic polymorphism; one carbon

Indexed keywords

CYCLOPHOSPHAMIDE; DIHYDROFOLATE REDUCTASE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; IRINOTECAN; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; METHOTREXATE; RALTITREXED; THYMIDYLATE SYNTHASE;

ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; CARBON METABOLISM; CLINICAL TRIAL; DNA METHYLATION; DRUG INHIBITION; GENETIC POLYMORPHISM; HUMAN; LIFESTYLE; MODULATION;

BREAST NEOPLASMS; DNA METHYLATION; FEMALE; FOLIC ACID; HUMANS; POLYMORPHISM, GENETIC;

EID: 64349101889     PISSN: 16738527     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1673-8527(08)60108-3     Document Type: Article

References (87)

1. Bailey L.B., and Gregory III J.F. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement. J. Nutr. 129 (1999) 919-922
2. Baylin S.B., Herman J.G., Graff J.R., Vertino P.M., and Issa J.P. Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv. Cancer Res. 72 (1998) 141-196
3. Baylin S.B., Esteller M., Rountree M.R., Bachman K.E., Schuebel K., and Herman J.G. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet. 10 (2001) 687-692
4. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., Wickramasinghe S.N., Everson R.B., and Ames B.N. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc. Natl. Acad. Sci. USA 94 (1997) 3290-3295
5. Castro R., Rivera I., Ravasco P., Camilo M.E., Jakobs C., Blom H.J., and de Almeida I.T. 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C→T and 1298A→C mutations are associated with DNA hypomethylation. J. Med. Genet. 41 (2004) 454-458
6. Chabner B. Cancer Chemotherapy and Biotherapy: Principles and Practice. 3rd ed. (2001), Lippincott-Raven Publishers, Philadelphia, PA
7. Chen J., Stampfer M.J., Ma J., Selhub J., Malinow M.R., Hennekens C.H., and Hunter D.J. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis 154 (2001) 667-672
8. Chen J., Gammon M.D., Chan W., Palomeque C., Wetmur J.G., Kabat G.C., Teitelbaum S.L., Britton J.A., Terry M.B., Neugut A.I., and Santella R.M. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res. 65 (2005) 1606-1614
9. Cho E., Holmes M., Hankinson S.E., and Willett W.C. Nutrients involved in one-carbon metabolism and risk of breast cancer among premenopausal women. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 2787-2790
10. Christman J.K., Sheikhnejad G., Dizik M., Abileah S., and Wainfan E. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis 14 (1993) 551-557
11. Clarke R. Prognostic and predictive factors. In: Harris J.R. (Ed). Disease of the Breast Vol. 2 (2000), Lippincott Williams & Wilkins, Philadelphia 489-514
12. Combs G.F. The Vitamins: Fundamental Aspects in Nutrition and Health (1992), Academic Press, San Diego, Calif.
13. Davis C.D., and Uthus E.O. DNA methylation, cancer susceptibility, and nutrient interactions. Exp. Biol. Med. 229 (2004) 988-995
14. Demark-Wahnefried W., Peterson B., McBride C., Lipkus I., and Clipp E. Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer 88 (2000) 674-684
15. Ericson U., Sonestedt E., Gullberg B., Olsson H., and Wirfalt E. High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmo Diet and Cancer cohort. Am. J. Clin. Nutr. 86 (2007) 434-443
16. Esteller M. Epigenetics in Cancer. N. Engl. J. Med. 358 (2008) 1148-1159
17. Fowler B.M., Giuliano A.R., Piyathilake C., Nour M., and Hatch K. Hypomethylation in cervical tissue: Is there a correlation with folate status? Cancer Epidemiol. Biomarkers Prev. 7 (1998) 901-906
18. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., and van den Heuvel L.P. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10 (1995) 111-113
19. Gaughan D.J., Kluijtmans L.A., Barbaux S., McMaster D., Young I.S., Yarnell J.W., Evans A., and Whitehead A.S. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157 (2001) 451-456
20. Goode E.L., Potter J.D., Bigler J., and Ulrich C.M. Methionine synthase D919G polymorphism, folate metabolism, and colorectal adenoma risk. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 157-162
21. Halsted C.H., Villanueva J.A., Devlin A.M., and Chandler C.J. Metabolic interactions of alcohol and folate. J. Nutr. 132 (2002) 2367S-2372S
22. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
23. Hannon-Fletcher M.P., Armstrong N.C., Scott J.M., Pentieva K., Bradbury I., Ward M., Strain J.J., Dunn A.A., Molloy A.M., Kerr M.A., and McNulty H. Determining bioavailability of food folates in a controlled intervention study. Am. J. Clin. Nutr. 80 (2004) 911-918
24. Harmon D.L., Shields D.C., Woodside J.V., McMaster D., Yarnell J.W., Young I.S., Peng K., Shane B., Evans A.E., and Whitehead A.S. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet. Epidemiol. 17 (1999) 298-309
25. Herman J.G. Hypermethylation of tumor suppressor genes in cancer. Semin. Cancer Biol. 9 (1999) 359-367
26. Horie N., Aiba H., Oguro K., Hojo H., and Takeishi K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct. Funct. 20 (1995) 191-197
27. Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline (1998), National Academies Press, Washington, DC
28. Jacob R.A., Gretz D.M., Taylor P.C., James S.J., Pogribny I.P., Miller B.J., Henning S.M., and Swendseid M.E. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J. Nutr. 128 (1998) 1204-1212
29. Jacques P.F., Bostom A.G., Selhub J., Rich S., Ellison R.C., Eckfeldt J.H., Gravel R.A., and Rozen R. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. Atherosclerosis 166 (2003) 49-55
30. Johnson W.G., Stenroos E.S., Spychala J.R., Chatkupt S., Ming S.X., and Buyske S. New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): A risk factor for spina bifida acting in mothers during pregnancy?. Am. J. Med. Genet. A 124 (2004) 339-345
31. Justenhoven C., Hamann U., Pierl C.B., Rabstein S., Pesch B., Harth V., Baisch C., Vollmert C., Illig T., Bruning T., Ko Y., and Brauch H. One-carbon metabolism and breast cancer risk: No association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 3015-3018
32. Kaneda S., Takeishi K., Ayusawa D., Shimizu K., Seno T., and Altman S. Role in translation of a triple tandemly repeated sequence in the 5′-untranslated region of human thymidylate synthase mRNA. Nuclear Acids Res. 15 (1987) 1259-1270
33. Kawakami K., Ruszkiewicz A., Bennett G., Moore J., Watanabe G., and Iacopetta B. The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase. Clin. Cancer Res. 9 (2003) 5860-5865
34. Lajous M., Romieu I., Sabia S., Boutron-Ruault M.C., and Clavel-Chapelon F. Folate, vitamin B12 and postmenopausal breast cancer in a prospective study of French women. Cancer Causes Control 17 (2006) 1209-1213
35. Larsson S.C., Giovannucci E., and Wolk A. Folate and risk of breast cancer: A meta-analysis. J. Natl. Cancer Inst. 99 (2007) 64-76
36. Lewis S.J., Harbord R.M., Harris R., and Smith G.D. Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. J. Natl. Cancer Inst. 98 (2006) 1607-1622
37. Lissowska J., Gaudet M.M., Brinton L.A., Chanock S.J., Peplonska B., Welch R., Zatonski W., Szeszenia-Dabrowska N., Park S., Sherman M., and Garcia-Closas M. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: A population-based case-control study and meta-analyses. Int. J. Cancer 120 (2007) 2696-2703
38. Luebeck E.G., Moolgavkar S.H., Liu A.Y., Boynton A., and Ulrich C.M. Does folic acid supplementation prevent or promote colorectal cancer? Results from model-based predictions. Cancer Epidemiol. Biomarkers Prev. 17 (2008) 1360-1367
39. Machlin L.J. Handbook of vitamins, 2nd ed., rev. and expanded. ed (1991), M. Dekker, New York
40. Macis D., Maisonneuve P., Johansson H., Bonanni B., Botteri E., Iodice S., Santillo B., Penco S., Gucciardo G., D'Aiuto G., Del Turco R.M., Amadori M., Costa A., and Decensi A. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: A nested-case-control study and a pooled meta-analysis. Breast Cancer Res. Treat. 106 (2007) 263-271
41. Mandola M.V., Stoehlmacher J., Zhang W., Groshen S., Yu M.C., Iqbal S., Lenz H.J., and Ladner R.D. A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels. Pharmacogenetics 14 (2004) 319-327
42. Maring J.G., Groen H.J., Wachters F.M., Uges D.R., and de Vries E.G. Genetic factors influencing pyrimidine-antagonist chemotherapy. Pharmacogenomics J. 5 (2005) 226-243
43. Martin D.N., Boersma B.J., Howe T.M., Goodman J.E., Mechanic L.E., Chanock S.J., and Ambs S. Association of MTHFR gene polymorphisms with breast cancer survival. BMC Cancer 6 (2006) 257
44. Maunsell E., Drolet M., Brisson J., Robert J., and Deschenes L. Dietary change after breast cancer: Extent, predictors, and relation with psychological distress. J. Clin. Oncol. 20 (2002) 1017-1025
45. McBride C.M., Clipp E., Peterson B.L., Lipkus I.M., and Demark-Wahnefried W. Psychological impact of diagnosis and risk reduction among cancer survivors. Psychooncology 9 (2000) 418-427
46. McEligot A.J., Largent J., Ziogas A., Peel D., and Anton-Culver H. Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer. Nutr. Cancer 55 (2006) 132-140
47. Miller J.W., Nadeau M.R., Smith J., Smith D., and Selhub J. Folate-deficiency-induced homocysteinaemia in rats: Disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism. Biochem. J. 298 Pt 2 (1994) 415-419
48. Niculescu M.D. Diet, methyl donors and DNA methylation: Interactions between dietary folate, methionine and choline. J. Nutr. 132 (2002) 2333S-2335S
49. Nijhout H.F., Reed M.C., Anderson D.F., Mattingly J.C., James S.J., and Ulrich C.M. Long-range allosteric interactions between the folate and methionine cycles stabilize DNA methylation reaction rate. Epigenetics 1 (2006) 81-87
50. Nijhout H.F., Reed M., Lam S., Shane B., Gregory J., and Ulrich C. In silico experimentation with a model of hepatic mitochondrial folate metabolism. Theor. Biol. Med. Model. 3 (2006) 40
51. Nijhout H.F., Reed M.C., Budu P., and Ulrich C.M. A mathematical model of the folate cycle: New insights into folate homeostasis. J. Biol. Chem. 279 (2004) 55008-55016
52. Paz M.F., Avila S., Fraga M.F., Pollan M., Capella G., Peinado M.A., Sanchez-Cespedes M., Herman J.G., and Esteller M. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res. 62 (2002) 4519-4524
53. Pullarkat S.T., Stoehlmacher J., Ghaderi V., Xiong Y.P., Ingles S.A., Sherrod A., Warren R., Tsao-Wei D., Groshen S., and Lenz H.J. Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics J. 1 (2001) 65-70
54. Rampersaud G.C., Kauwell G.P., Hutson A.D., Cerda J.J., and Bailey L.B. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am. J. Clin. Nutr. 72 (2000) 998-1003
55. Reed M.C., Nijhout H.F., Neuhouser M.L., Gregory III J.F., Shane B., James S.J., Boynton A., and Ulrich C.M. A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism. J. Nutr. 136 (2006) 2653-2661
56. Rohan T.E., Jain M.G., Howe G.R., and Miller A.B. Dietary folate consumption and breast cancer risk. J. Natl. Cancer Inst. 92 (2000) 266-269
57. Rossi E., Hung J., Beilby J.P., Knuiman M.W., Divitini M.L., and Bartholomew H. Folate levels and cancer morbidity and mortality: Prospective cohort study from Busselton, Western Australia. Ann. Epidemiol. 16 (2006) 206-212
58. Russo J., Yang X., Hu Y.F., Bove B.A., Huang Y., Silva I.D., Tahin Q., Wu Y., Higgy N., Zekri A., and Russo I.H. Biological and molecular basis of human breast cancer. Front. Biosci. 3 (1998) D944-D960
59. Salminen E.K. Does breast cancer change patients' dietary habits? Eur. J. Clin. Nutr. 54 (2000) 844-848
60. Sauberlich H.E., Kretsch M.J., Skala J.H., Johnson H.L., and Taylor P.C. Folate requirement and metabolism in nonpregnant women. Am. J. Clin. Nutr. 46 (1987) 1016-1028
61. Sellers T.A., Kushi L.H., Cerhan J.R., Vierkant R.A., Gapstur S.M., Vachon C.M., Olson J.E., Therneau T.M., and Folsom A.R. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology 12 (2001) 420-428
62. Sellers T.A., Alberts S.R., Vierkant R.A., Grabrick D.M., Cerhan J.R., Vachon C.M., Olson J.E., Kushi L.H., and Potter J.D. High-folate diets and breast cancer survival in a prospective cohort study. Nutr. Cancer 44 (2002) 139-144
63. Shrubsole M.J., Shu X.O., Ruan Z.X., Cai Q., Cai H., Niu Q., Gao Y.T., and Zheng W. MTHFR genotypes and breast cancer survival after surgery and chemotherapy: A report from the Shanghai Breast Cancer Study. Breast Cancer Res. Treat. 91 (2005) 73-79
64. Shrubsole M.J., Gao Y., Cai Q., Shu X.O., Dai Q., Jin F., and Zheng W. MTR and MTRR polymorphisms, dietary intake, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 586-588
65. Sohn K., Croxford R., Yates Z., Lucock M., and Kim Y. Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate. J. Natl. Cancer Inst. 96 (2004) 134-144
66. Stern L.L., Mason J.B., Selhub J., and Choi S.W. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 849-853
67. Stevens V.L., McCullough M.L., Pavluck A.L., Talbot J.T., Feigelson H.S., Thun M.J., and Calle E.E. Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 1140-1147
68. Stevenson J.P., Redlinger M., Kluijtmans L.A., Sun W., Algazy K., Giantonio B., Haller D.G., Hardy C., Whitehead A.S., and O'Dwyer P.J. Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancer. J. Clin. Oncol. 19 (2001) 4081-4087
69. Stolzenberg-Solomon R.Z., Chang S.C., Leitzmann M.F., Johnson K.A., Johnson C., Buys S.S., Hoover R.N., and Ziegler R.G. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am. J. Clin. Nutr. 83 (2006) 895-904
70. Toffoli G., Veronesi A., Boiocchi M., and Crivellari D. MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF). Ann. Oncol. 11 (2000) 373-374
71. Ulrich C.M., Curtin K., Samowitz W., Bigler J., Potter J.D., Caan B., and Slattery M.L. MTHFR variants reduce the risk of G: C→A:T transition mutations within the p53 tumor suppressor gene in colon tumors. J. Nutr. 135 (2005) 2462-2467
72. Ulrich C.M., Bigler J., Velicer C.M., Greene E.A., Farin F.M., and Potter J.D. Searching expressed sequence tag databases: Discovery and confirmation of a common polymorphism in the Thymidylate Synthase gene. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 1381-1385
73. Ulrich C.M., Nijhout H.F., and Reed M.C. Mathematical modeling: Epidemiology meets systems biology. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 827-829
74. Ulrich C.M. Folate and cancer prevention: A closer look at a complex picture. Am. J. Clin. Nutr. 86 (2007) 271-273
75. Ulvik A., Ueland P.M., Fredriksen A., Meyer K., Vollset S.E., Hoff G., and Schneede J. Functional inference of the methylenetetrahydrofolate reductase 677C>T and 1298A>C polymorphisms from a large-scale epidemiological study. Hum. Genet. 121 (2007) 57-64
76. van Engeland M., Weijenberg M.P., Roemen G.M., Brink M., de Bruine A.P., Goldbohm R.A., van den Brandt P.A., Baylin S.B., de Goeij A.F., and Herman J.G. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: The Netherlands cohort study on diet and cancer. Cancer Res. 63 (2003) 3133-3137
77. Velicer C.M., and Ulrich C.M. Vitamin and mineral supplement use among US adults after cancer diagnosis: A systematic review. J. Clin. Oncol. 26 (2008) 665-673
78. Weisberg I.S., Jacques P.F., Selhub J., Bostom A.G., Chen Z., Curtis E.R., Eckfeldt J.H., and Rozen R. The 1298A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expressio and association with homocysteine. Atherosclerosis 156 (2001) 409-415
79. Widschwendter M., and Jones P.A. DNA methylation and breast carcinogenesis. Oncogene 21 (2002) 5462-5482
80. 12) increases risk for spina bifida. Mol. Genet. Metab. 67 (1999) 317-323
81. Xu X., Gammon M.D., Wetmur J.G., Rao M., Gaudet M.M., Teitelbaum S.L., Britton J.A., Neugut A.I., Santella R.M., and Chen J. A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users. Am. J. Clin. Nutr. 85 (2007) 1098-1102
82. Xu X., Gammon M.D., Zhang H., Wetmur J.G., Rao M., Teitelbaum S.L., Britton J.A., Neugut A.I., Santella R.M., and Chen J. Polymorphisms of one-carbon metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis 28 (2007) 1504-1509
83. Xu X., Gammon M.D., Zeisel S.H., Lee Y.L., Wetmur J.G., Teitelbaum S.L., Bradshaw P.T., Neugut A.I., Santella R.M., and Chen J. Choline metabolism and risk of breast cancer in a population-based study. FASEB J. 22 (2008) 2045-2052
84. Xu X., Gammon M.D., Wetmur J.G., Bradshaw P.T., Teitelbaum S.L., Neugut A.I., Santella R.M., and Chen J. B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer. Cancer Epidemiol. Biomarkers Prev. 17 (2008) 2109-2116
85. Young R.C. Mechanisms to improve chemotherapy effectiveness. Cancer 65 (1990) 815-822
86. Zhang S., Hunter D.J., Hankinson S.E., Giovannucci E.L., Rosner B.A., Colditz G.A., Speizer F.E., and Willett W.C. A prospective study of folate intake and the risk of Breast Cancer. JAMA 281 (1999) 1632-1637
87. Zintzaras E. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: A meta-analysis. Clin. Genet. 69 (2006) 327-336